Drs. Karen Rabin and Alex George were chosen to receive grant funding of $50,000 each by the The Pediatric Pilot Awards Research Grant Program, giving them the opportunity to continue and build upon their current research.
As gene sequencing technologies rapidly advance and new genomic data becomes available, so does the need for a better understanding and consensus on which gene changes are relevant to diagnosis and treatment.
The Benefit Homes Project of the GHBA has contributed more than $1.2 million over the last 25 years, making research advances possible that allow patients, such as Morgan, to live more comfortably while battling childhood cancer.
Treatment for sickle cell disease has largely focused on managing pain and acute complications, but current research is now aimed at developing more efficient and progressive forms of treatment that could potentially benefit patients around the world.